Brain implant offers new hope for rare, severe epilepsy

NCT ID NCT05339126

First seen Jan 12, 2026 · Last updated Apr 25, 2026 · Updated 12 times

Summary

This study tests a brain-responsive neurostimulation system (RNS) in 24 people aged 12 and older with Lennox-Gastaut syndrome, a severe form of epilepsy that doesn't respond to medication. The device is implanted in the brain and delivers small electrical pulses to stop seizures before they start. The goal is to see if it safely reduces the number of drop seizures by at least 35%.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Emory University

    Atlanta, Georgia, 30322, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

  • Mount Sinai Hospital

    New York, New York, 10029, United States

  • NYU Langone Medical Center

    New York, New York, 10016, United States

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35294, United States

  • University of California, San Francisco

    San Francisco, California, 94143, United States

Conditions

Explore the condition pages connected to this study.